2 Patents
- US126178502026Treatment of Pd-l1-positive Melanoma Using an Anti-pd-1 Antibody
Bristol-myers Squibb Company
0 cites - US125901532026Treatment of Pd-l1-negative Melanoma Using an Anti-pd-1 Antibody and an Anti-ctla-4 Antibody
Bristol-myers Squibb Company
0 cites